A placebo controlled clinical study to study effectiveness of Sahadevi Eye drop in Timira(Immature cataract)

A prospective randomized placebo-controlled clinical study to evaluate the therapeutic effect of Sahadevi (Cyanthillium cinerarium (L.) H. Rob) eye drops in Timira with special reference to immature cataract. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085111

Enrollment

Registered

2025-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having immature cataract

Exclusion criteria

Exclusion criteria: 1. Patients suffering from inflammatory and infective disease of eyeball and its appendages. 2. Patients who are suffering from congenital cataract, mature and hyper mature cataract, traumatic cataract. 3. Any systemic disease and/or medication that interferes with the intervention of current study.

Design outcomes

Primary

Measure	Time frame
Improvement in visual acuity (distance and near) assessed by Snellen s and Jaeger s chartsTimepoint: 45 days	—

Secondary

Measure	Time frame
1.Reduction in symptoms such as glare, diplopia, and floaters based on patient-reported outcomes. Timepoint: 45 days;2.Change in cataract grade assessed by slit lamp examination and LOCS III classification. Timepoint: 45 days;3.Assessment of safety and tolerability through adverse drug reaction monitoringTimepoint: 45 days	—

Countries

India

Contacts

Public ContactGanesh Tejasvi S

Parul Institute of Ayurved and Research

ganeshtejasvi@gmail.com9164774710

Outcome results